Yoshiyasu Takefuji

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Venues

Eye (London, England)

Biomedicines

Journal of thrombosis and thrombolysis

International journal of molecular sciences

Keio University

Keio University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Keio University Apr 01 1992

Japan

Professor :: Environment and Information Studies

Education History

Keio University Apr 01 1980 - Mar 31 1983

Japan

PHD :: Electrical Engineering

Publications

Shin-Ichi Hirano, Yoshiyasu Takefuji
Molecular Hydrogen Protects against Various Tissue Injuries from Side Effects of Anticancer Drugs by Reducing Oxidative Stress and Inflammation. Biomedicines 12 (7) (2024)
Yoshiyasu Takefuji
Eye diseases: a global concern across age, race, and environment. Eye (London, England) (2024)
Yoshiyasu Takefuji
Herpes zoster ophthalmicus: COVID-19 impact and clinical implications. Eye (London, England) (2024)
Yoshiyasu Takefuji
Generative AI for diabetologists: a concise tutorial on dataset analysis. Journal of diabetes and metabolic disorders 23 (1) (2024)
Yoshiyasu Takefuji
Hydrogen inhalation therapy for inflammation and eye diseases: a review of the literature. Eye (London, England) (2024)
Shin-Ichi Hirano, Yoshiyasu Takefuji
Molecular Hydrogen Protects against Various Tissue Injuries from Side Effects of Anticancer Drugs by Reducing Oxidative Stress and Inflammation. Biomedicines 12 (7) (2024)
Yoshiyasu Takefuji
Drug-induced macular oedema. Eye (London, England) (2024)
Yoshiyasu Takefuji
Burnout among ophthalmologists: a global review, gender impact, and the role of AI in mitigation. Eye (London, England) (2024)
Yoshiyasu Takefuji
Generative AI for diabetologists: a concise tutorial on dataset analysis. Journal of diabetes and metabolic disorders 23 (1) (2024)
Shin-Ichi Hirano, Yoshiyasu Takefuji
Molecular Hydrogen Protects against Various Tissue Injuries from Side Effects of Anticancer Drugs by Reducing Oxidative Stress and Inflammation. Biomedicines 12 (7) (2024)
Shin-Ichi Hirano, Yusuke Ichikawa, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh
Clinical Use and Treatment Mechanism of Molecular Hydrogen in the Treatment of Various Kidney Diseases including Diabetic Kidney Disease. Biomedicines 11 (10) (2023)
Toshiki Miyagawa, Yoshiyasu Takefuji
A time-series COVID-19 policy outcome analysis tool to measure human behavior from a herd instinct perspective. Health and technology (2023)
Toshiki Miyagawa, Yoshiyasu Takefuji
A time-series COVID-19 policy outcome analysis tool to measure human behavior from a herd instinct perspective. Health and technology (2023)
Yoshiyasu Takefuji
Frailty and eye diseases: a review of the literature. Eye (London, England) (2023)
Yoshiyasu Takefuji
Artificial intelligence universal biomarker prediction tool. Journal of thrombosis and thrombolysis 57 (2) (2023)
Yoshiyasu Takefuji
Artificial intelligence universal biomarker prediction tool. Journal of thrombosis and thrombolysis (2023)
Yoshiyasu Takefuji
Artificial intelligence universal biomarker prediction tool. Journal of thrombosis and thrombolysis 57 (2) (2023)
Yoshiyasu Takefuji
Artificial intelligence universal biomarker prediction tool. Journal of thrombosis and thrombolysis 57 (2) (2023)
Yoshiyasu Takefuji
Policy analysis and data mining tools for controlling COVID-19 policies. Network modeling and analysis in health informatics and bioinformatics 12 (1) (2022)
Yoshiyasu Takefuji
COVID-19 policy analysis for 10 European countries. Zeitschrift fur Gesundheitswissenschaften = Journal of public health (2022)
Yoshiyasu Takefuji
Deathdaily: A Python Package Index for predicting the number of daily COVID-19 deaths. Network modeling and analysis in health informatics and bioinformatics 11 (1) (2022)
Yoshiyasu Takefuji
A herd immunity approach to the COVID-19 pandemic? Health and technology 12 (5) (2022)
Yoshiyasu Takefuji
Policy analysis and data mining tools for controlling COVID-19 policies. Network modeling and analysis in health informatics and bioinformatics 12 (1) (2022)
Haru Yamamoto, Yusuke Ichikawa, Shin-Ichi Hirano, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh
Molecular Hydrogen as a Novel Protective Agent against Pre-Symptomatic Diseases. International journal of molecular sciences 22 (13) (2021)
Yoshiyasu Takefuji
Analysis of digital fences against COVID-19. Health and technology (2021)
Shin-Ichi Hirano, Haru Yamamoto, Yusuke Ichikawa, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh
Molecular Hydrogen as a Novel Antitumor Agent: Possible Mechanisms Underlying Gene Expression. International journal of molecular sciences 22 (16) (2021)
Shin-Ichi Hirano, Yusuke Ichikawa, Bunpei Sato, Haru Yamamoto, Yoshiyasu Takefuji, Fumitake Satoh
Potential Therapeutic Applications of Hydrogen in Chronic Inflammatory Diseases: Possible Inhibiting Role on Mitochondrial Stress. International journal of molecular sciences 22 (5) (2021)
Shin-Ichi Hirano, Yusuke Ichikawa, Bunpei Sato, Haru Yamamoto, Yoshiyasu Takefuji, Fumitake Satoh
Molecular Hydrogen as a Potential Clinically Applicable Radioprotective Agent. International journal of molecular sciences 22 (9) (2021)
Yoshiyasu Takefuji
Fourier analysis using the number of COVID-19 daily deaths in the US. Epidemiology and infection 149 (2021)
Yoshiyasu Takefuji
Detection and protection mechanisms against vulnerabilities are needed in blockchain applications. European journal of human genetics : EJHG 28 (6) (2020)

Yoshiyasu Takefuji.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshiyasu Takefuji